- 最后登录
- 2011-10-15
- 在线时间
- 152 小时
- 寄托币
- 302
- 声望
- 16
- 注册时间
- 2009-8-25
- 阅读权限
- 20
- 帖子
- 4
- 精华
- 0
- 积分
- 334
- UID
- 2688235
 
- 声望
- 16
- 寄托币
- 302
- 注册时间
- 2009-8-25
- 精华
- 0
- 帖子
- 4
|
57, The following appeared in a newsletter on nutrition and health.
"Although the multimineral Zorba pill was designed as a simple dietary supplement, a study of first-time ulcer patients who took Zorba suggests that Zorba actually helps prevent ulcers. The study showed that only 25 percent of those ulcer patients who took Zorba under a doctor's direction developed new ulcers, compared to a 75 percent recurrence rate among ulcer patients who did not take Zorba. Clearly, then, Zorba will be highly effective in preventing recurrent ulcers and if health experts inform the general public of this fact, many first-time ulcers can be prevented as well."
The arguer suggested, but did not prove, that Zorba will be highly effective in preventing recurrent ulcers and if health experts inform the general public of this fact, many first-time ulcers can be prevented as well , in this argument. After a careful consideration, we will uncover how groundless the conclusion that the arguer maintained is.
The evidence that the arguer cited, being based on the study that showed only 25 percent of those ulcer patients who took Zorba under a doctor’s direction developed new ulcers, compared to a 75 percent recurrence rate among ulcer patients who did not take Zorba, did not lend a strong support to the conclusion that the arguer got. First of all, no evidence shows that the two groups of ulcer patients who are studied in this experiment were given the same treatment other than the Zorba. We do not know if the effect that control group and the experiment group appeared result from another kind of medicine that the patients took. If so, it is clearly that the arguer’s claim is fallacy.
Moreover, granted that the fact that Zorba will be highly effective in preventing recurrent ulcers is true, the arguer fails to take account into the another fact that some ulcer patients who might have an allergy to Zorba, and Zorba might have serious side-effect to people. In cognition to this point, We cannot agree that those people should take Zorba for reducing their rate of recurrent ulcers.
In addition, the arguer commits a fallacy of generations because the arguer did not mention that what kinds of ulcer patients constituted the two groups, how many ulcer patients they researched before they got the conclusion over all. If they just studied several ulcer patients who can not represent all ulcer parents from slight ulcer to severe ulcer in this experiment, we do not agree that the argument the arguer maintains as well.
Finally, even though all of above can be proved to support the conclusion the arguer got, we still not agree that if health experts inform the general public of this fact, many first-time ulcers can be prevented as well. As the evidence indication, Zorba might reduce the recurrence of the ulcers, no evidence shows that it can prevent the first-time ulcers. We all know that the first-time ulcers maybe have different causes from the recurrence of the ulcers, we can not place reliance on the Zorba that will prevent ulcer broken from all reasons that can cause ulcer. Furthermore it is possible that the first-time ulcer patient’s experience would aid them to avoid the recurrence of recurrence with the Zorba together, yet people who have not these experience might not avoid the first-time ulcer broken well
In sum, before providing more information and details, the arguer cannot conclude such unconvincing conclusion. |
|